About Cephalon

Cephalon is one of the world's fastest-growing biopharmaceutical companies. We are driven by our mission to deliver industry-leading growth by achieving the most efficient and sustainable means of delivering new value to the marketplace. Cephalon specializes in drugs to treat and manage neurological diseases, sleep disorders, cancer, and pain. We employ approximately 3,000 people worldwide with operations in the United States and Europe.

From discovery research into drug candidates to development of late-stage compounds and existing products, Cephalon's global R&D organization is equipped to mobilize resources and industry-leading talent at every point on the drug development continuum. As a result, we advance drugs quickly and at whatever stage our research effort commences, and at any level of research complexity.

To learn more about Cephalon or its products, visit us at www.Cephalon.com.
To learn more about our oncology franchise, please visit www.CephalonOncology.com.